ATC Group: N06CA03 Fluoxetine and psycholeptics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N06CA03 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N06 Psychoanaleptics
3 N06C Psycholeptics and psychoanaleptics in combination
4 N06CA Antidepressants in combination with psycholeptics
5 N06CA03

Related product monographs

Title Information Source Document Type  
SYMBYAX Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Mexico (MX)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.